HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,851 | +12.5% | 2,661 | +0.0% | 0.07% | +7.7% |
| Q2 2023 | $273,581 | -5.8% | 2,660 | 0.0% | 0.06% | -5.8% |
| Q1 2023 | $290,312 | -10.8% | 2,660 | -7.0% | 0.07% | -10.4% |
| Q4 2022 | $325,468 | +41.5% | 2,860 | -0.9% | 0.08% | +42.6% |
| Q2 2022 | $230,000 | -25.6% | 2,885 | -1.7% | 0.05% | -14.3% |
| Q1 2022 | $309,000 | -4.0% | 2,935 | -1.7% | 0.06% | -7.4% |
| Q4 2021 | $322,000 | -17.4% | 2,985 | -16.2% | 0.07% | -22.7% |
| Q3 2021 | $390,000 | +17.8% | 3,562 | +0.8% | 0.09% | +17.3% |
| Q2 2021 | $331,000 | +3.4% | 3,535 | +1.7% | 0.08% | -8.5% |
| Q1 2021 | $320,000 | +25.5% | 3,475 | -0.4% | 0.08% | +17.1% |
| Q4 2020 | $255,000 | -5.9% | 3,490 | 0.0% | 0.07% | -16.7% |
| Q3 2020 | $271,000 | +35.5% | 3,490 | -3.1% | 0.08% | +12.0% |
| Q2 2020 | $200,000 | -66.4% | 3,600 | -78.1% | 0.08% | -68.8% |
| Q4 2019 | $596,000 | – | 16,455 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |